Skip to content

SETON trial

loose seton prior to surgery for single-tract cryptoglandular fistula vs no seton: a multicenter randomised study - SETON trial: loose seton vs no seton in simple cryptoglandular fistula

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58307
Enrollment
277
Registered
2025-07-02
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anal fistula, anorectal fistula, perianal fistula, cryptoglandular fistula, seton drainage anal fistula

Interventions

Group A:&nbsp
Patients receive a loose seton prior to definitive fistula surgery (two-stage procedure), which is currently considered standard care in the Netherlands.Group B: Patients proceed directly to definitiv

Sponsors

Proctos Kliniek
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Men and women aged 18 years or olderSingle tract mid-high or high cryptoglandular anal fistulaEligible for e-mail questionnairesSufficient understanding of the Dutch written language (reading and writing)Obtained written informed consent

Exclusion criteria

Exclusion criteria: Presence of an anorectal abscessMultiple or complex anorectal fistulasDiagnosis of inflammatory bowel diseaseHistory of anorectal malignancyUse of immunosuppressive medication at the time of surgeryHistory of pelvic radiationPregnancy or lactation

Design outcomes

Primary

MeasureTime frame
The main outcome of the study is fistula closure at 26 weeks following the final surgical intervention. Determined through the absence of fistula related symptoms (pain and/or leakage of fluids or pus) and if necessary confirmed with ultrasound or MRI.

Secondary

MeasureTime frame
Patient-reported outcome measures (PROMs): Vaizey incontinence score and FIQL (Fecal Incontinence Quality of Life scale)Clinical outcomes: fistula recurrence, postoperative complications, need for re-interventions, pain intensity (VAS score), return to workQuality of life: Measured at 12 months using the EQ-5D-5LBoth in-hospital direct and indirect costs will be analyzed using EQ-5D and incremental cost analysisOut-of-hospital postoperative costs will also be includedAnal Fistula Core Outcome Set (AFCOS)

Countries

Netherlands

Contacts

Public ContactA.A. Elwakel

Amsterdam UMC

a.elwakel@procotoskliniek.nl0613489317

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026